comparemela.com

Latest Breaking News On - Intermediate dry age related macular degeneration - Page 1 : comparemela.com

AffaMed Therapeutics Announces Clinical Trial Application Approval in Mainland China for Risuteganib (Luminate®) First-in-Class Candidate for the Treatment of Intermediate Dry AMD

/PRNewswire/ AffaMed Therapeutics ("AffaMed"), a global biotechnology company dedicated to developing and commercializing transformative pharmaceutical,.

Hong kongDayao zhaoHanmi pharmaceuticalsAffamed therapeutics ltdChina national medical products administrationDrug administrationAllegro ophthalmicHanmi pharmaceutical co ltdAmed therapeuticsNational medical products administrationClinical trial applicationIntermediate dry age related macular degenerationAffamed therapeuticsGreater chinaIntermediate drySpecial protocol assessment

Curative Biotechnology, Inc ?: Curative Biotechnology Announces Completion of IND Enabling Reformulated Metformin HCL Eye Drop Study

Boca Raton, FL, Jan. 05, 2023 (GLOBE NEWSWIRE) Curative Biotechnology Inc. (OTC: CUBT) ("Curative Biotech" or the "Company"), a development-stage biomedical company focused on novel treatments for rare

Paul michaelsSteve chizzikBoca ratonDevelopment agreementSecurities exchangeCurative biotechnology incInvestigational new drugToxicology studyTopical instillationCurative biotechnologyIntermediate dry age related macular degenerationGeographical atrophyCooperative researchNational eye instituteNational institutesBethesda maryland

vimarsana © 2020. All Rights Reserved.